Troy Short Joins Nanoscope Therapeutics as Senior Vice President of Manufacturing and Supply Chain
Nanoscope Therapeutics has appointed Troy Short as its new Senior Vice President, Manufacturing and Supply Chain. With over two decades of experience in GMP manufacturing and gene therapy supply chain operations, Short previously led the global commercial launch of Zolgensma® at AveXis before joining Novartis. He also held leadership roles at Jaguar Gene Therapy and Advanced Medicine Partners. Short will oversee Nanoscope's efforts to scale up production and distribution for MOGENRY™ (sonpiretigene isteparvovec; MCO-010), the company’s lead gene therapy candidate, which is currently under regulatory review by both the FDA in the U.S. and PMDA in Japan. The appointment underscores Nanoscope's commitment to preparing a robust supply chain for global commercialization of MOGENRY™ as it progresses through its regulatory pathway.
Tickers: $NVS